// App-Quantinova.ai

e16540 : IV vitamin C with chemotherapy for cisplatin ineligible bladder cancer patients (CI-MIBC) first-stage analysis NCT04046094.

Researchers

Presenter

  • Rahul Atul Parikh

Principal Investigators

  • John A. Taylor

  • Qi Chen

  • Benjamin L. Woolbright

  • Ping Chen

  • Elizabeth Marie Wulff-Burchfield

  • Jeffrey Holzbeierlein

  • Roy A. Jensen

  • Jeanne A. Drisko

Medical Centers

  • University of Kansas Medical Center, Westwood, KS

  • Department of Microbiology, University of Kansas Medical Center, Kansas City, KS

  • University of Kansas, Kansas City, KS

  • University of Kansas Medical Center, Department of Biostatistics, Kansas City, KS

  • Department of Pharmacology, University of Kansas, Kansas City, KS

  • University of Kansas Medical Center, Westwood, KS

  • University of Kansas Medical Center, Kansas City, MO

  • The University of Kansas Cancer Center, Kansas City, KS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT04046094

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved